Evidence map›Paper›PMID 37273993›Full record

ArticleInternational journal of bioprinting2023

Mammalian-specific decellularized matrices derived bioink for bioengineering of liver tissue analogues: A review.

Tanveer Ahmad Mir, Makoto Nakamura, Shinji Sakai, Shintaroh Iwanaga, Shadil Ibrahim Wani, Alaa Alzhrani, Kenichi Arai, Bilal Ahmed Mir, Shadab Kazmi, Abdullah M Assiri and 1 more

Abstract read
In one paragraph

Article in International journal of bioprinting, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Tanveer Ahmad MirTransplant Research and Innovation Department, Tissue/Organ Bioengineering & BioMEMS Laboratory, Organ Transplant Centre of Excellence, King Faisal Specialist Hospital and Research Centre, Riyadh 11211, KSA.
Makoto NakamuraDivision of Biomedical System Engineering, Graduate School of Science and Engineering, University of Toyama, Toyama 930-8555, Japan.
Shinji SakaiDivision of Chemical Engineering, Department of Materials Engineering Science, Graduate School of Engineering Science, Osaka University, Toyonaka, Osaka 560-8531, Japan.
Shintaroh IwanagaDivision of Biomedical System Engineering, Graduate School of Science and Engineering, University of Toyama, Toyama 930-8555, Japan.
Shadil Ibrahim WaniDivision of Biomedical System Engineering, Graduate School of Science and Engineering, University of Toyama, Toyama 930-8555, Japan.
Alaa AlzhraniTransplant Research and Innovation Department, Tissue/Organ Bioengineering & BioMEMS Laboratory, Organ Transplant Centre of Excellence, King Faisal Specialist Hospital and Research Centre, Riyadh 11211, KSA.
Kenichi AraiDepartment of Clinical Biomaterial Applied Science, Faculty of Medicine, University of Toyama, Toyama 930-0194, Japan.
Bilal Ahmed MirDivision of Intellectual Information Engineering, Graduate School of Science and Engineering, University of Toyama, Toyama 930-8555, Japan.
Shadab KazmiTransplant Research and Innovation Department, Tissue/Organ Bioengineering & BioMEMS Laboratory, Organ Transplant Centre of Excellence, King Faisal Specialist Hospital and Research Centre, Riyadh 11211, KSA.
Abdullah M AssiriTransplant Research and Innovation Department, Tissue/Organ Bioengineering & BioMEMS Laboratory, Organ Transplant Centre of Excellence, King Faisal Specialist Hospital and Research Centre, Riyadh 11211, KSA.
Dieter C BroeringTransplant Research and Innovation Department, Tissue/Organ Bioengineering & BioMEMS Laboratory, Organ Transplant Centre of Excellence, King Faisal Specialist Hospital and Research Centre, Riyadh 11211, KSA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The absolute shortage of compatible liver donors and the growing number of potential recipients have led scientists to explore alternative approaches to providing tissue/ organ substitutes from bioengineered sources. Bioartificial regeneration of a fully functional tissue/organ replacement is highly dependent on the right combination of engineering tools, biological principles, and materiobiology horizons. Over the past two decades, remarkable achievements have been made in hepatic tissue engineering by converging various advanced interdisciplinary research approaches. Three-dimensional (3D) bioprinting has arisen as a promising state-of-the-art tool with strong potential to fabricate volumetric liver tissue/organ equivalents using viscosity- and degradation-controlled printable bioinks composed of hydrous microenvironments, and formulations containing living cells and associated supplements. Source of origin, biophysiochemical, or thermomechanical properties and crosslinking reaction kinetics are prerequisites for ideal bioink formulation and realizing the bioprinting process. In this review, we delve into the forecast of the potential future utility of bioprinting technology and the promise of tissue/organ- specific decellularized biomaterials as bioink substrates. Afterward, we outline various methods of decellularization, and the most relevant studies applying decellularized bioinks toward the bioengineering of

Indexed as

BiofabricationBioinkBioprintingDecellularizationLiver tissue engineeringTranslational regenerative medicine

Identifiers

PMID37273993
PMCPMC10236352

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.